The patient is a female, 52 years old. She was found to have pancreatic cancer at the end of last year, mainly in the neck of the pancreas, which had invaded the common hepatic artery and other important blood vessels. The patient came to our clinic in early January of this year. Our strategy was: open abdominal exploration, tumor aspiration biopsy for clear diagnosis, iodine 125 particle implantation of pancreatic tumor under direct vision, intraperitoneal chemotherapy pump implantation, and active APC-CIK cellular immunotherapy under the premise of tumor load control by internal radiation therapy and chemotherapy. Intraoperatively, several metastatic nodules of 0.5 cm in size were found on the surface of the liver, which were immediately confirmed as “metastatic adenocarcinoma” by cryopathology. Considering that the metastatic tumor load in the liver was small, the preoperative strategy of iodine 125 particle implantation in pancreatic tumor, intraperitoneal chemotherapy pump implantation and postoperative sequential treatment with intraperitoneal chemotherapy and APC-CIK cellular immunotherapy was carried out, and the patient’s appearance was basically the same as before surgery except for some weight loss; meanwhile, the liver metastasis did not progress significantly. The following photos are the CT data of 1.7, 2.27 (one month after surgery), 3.26 and 5.24 this year, respectively, for your reference.